These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37589914)

  • 41. Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver Transplantation.
    Míková I; Neřoldová M; Hubáček JA; Dlouhá D; Jirsa M; Honsová E; Sticová E; Lánská V; Špičák J; Trunečka P
    Transplantation; 2020 Mar; 104(3):526-534. PubMed ID: 31356578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians.
    Stickel F; Buch S; Lau K; Meyer zu Schwabedissen H; Berg T; Ridinger M; Rietschel M; Schafmayer C; Braun F; Hinrichsen H; Günther R; Arlt A; Seeger M; Müller S; Seitz HK; Soyka M; Lerch M; Lammert F; Sarrazin C; Kubitz R; Häussinger D; Hellerbrand C; Bröring D; Schreiber S; Kiefer F; Spanagel R; Mann K; Datz C; Krawczak M; Wodarz N; Völzke H; Hampe J
    Hepatology; 2011 Jan; 53(1):86-95. PubMed ID: 21254164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PNPLA3 rs738409 associates with alcoholic liver cirrhosis but not with serum levels of IL6, IL10, IL8 or CCL2 in the Russian population.
    Peregud DI; Baronets VY; Lobacheva AS; Ivanov AS; Arisheva OS; Garmash IV; Kobalava ZD; Pirozhkov SV; Terebilina NN
    Ann Hepatol; 2021; 20():100247. PubMed ID: 32871288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population.
    Rashu EB; Werge MP; Hetland LE; Thing M; Nabilou P; Kimer N; Junker AE; Jensen AH; Nordestgaard BG; Stender S; Gluud LL
    Clin Res Hepatol Gastroenterol; 2024 Aug; 48(7):102389. PubMed ID: 38830575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease.
    Wu JT; Liu SS; Xie XJ; Liu Q; Xin YN; Xuan SY
    Lipids Health Dis; 2020 Feb; 19(1):29. PubMed ID: 32093693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis.
    Israelsen M; Juel HB; Detlefsen S; Madsen BS; Rasmussen DN; Larsen TR; Kjærgaard M; Fernandes Jensen MJ; Stender S; Hansen T; Krag A; Thiele M;
    Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1784-1794.e9. PubMed ID: 33279778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
    Nakamura M; Kanda T; Nakamoto S; Miyamura T; Jiang X; Wu S; Yokosuka O
    PLoS One; 2013; 8(12):e81312. PubMed ID: 24349054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study.
    Vespasiani-Gentilucci U; Dell'Unto C; De Vincentis A; Baiocchini A; Delle Monache M; Cecere R; Pellicelli AM; Giannelli V; Carotti S; Galati G; Gallo P; Valentini F; Del Nonno F; Rosati D; Morini S; Antonelli-Incalzi R; Picardi A
    Can J Gastroenterol Hepatol; 2018; 2018():7564835. PubMed ID: 29732362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease.
    Koo BK; Joo SK; Kim D; Bae JM; Park JH; Kim JH; Kim W
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1277-1285. PubMed ID: 29193269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis.
    Mederacke YS; Kirstein MM; Großhennig A; Marhenke S; Metzler F; Manns MP; Vogel A; Mederacke I
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1160-1168. PubMed ID: 32323349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease.
    Grimaudo S; Pipitone RM; Pennisi G; Celsa C; Cammà C; Di Marco V; Barcellona MR; Boemi R; Enea M; Giannetti A; Spatola F; Marchesini G; Craxì A; Petta S
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):935-944.e3. PubMed ID: 31419571
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Lisboa QC; Nardelli MJ; Pereira PA; Miranda DM; Ribeiro SN; Costa RSN; Versiani CA; Vidigal PVT; Ferrari TCA; Couto CA
    World J Hepatol; 2020 Oct; 12(10):792-806. PubMed ID: 33200017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients.
    Enomoto H; Aizawa N; Hasegawa K; Ikeda N; Sakai Y; Yoh K; Takata R; Yuri Y; Kishino K; Shimono Y; Ishii N; Takashima T; Nishimura T; Nishikawa H; Iwata Y; Iijima H; Nishiguchi S
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients.
    Vespasiani-Gentilucci U; Gallo P; Porcari A; Carotti S; Galati G; Piccioni L; De Vincentis A; Dell'Unto C; Vorini F; Morini S; Riva E; Picardi A
    Scand J Gastroenterol; 2016 Aug; 51(8):967-73. PubMed ID: 27150500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease.
    Trépo E; Gustot T; Degré D; Lemmers A; Verset L; Demetter P; Ouziel R; Quertinmont E; Vercruysse V; Amininejad L; Deltenre P; Le Moine O; Devière J; Franchimont D; Moreno C
    J Hepatol; 2011 Oct; 55(4):906-12. PubMed ID: 21334404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism.
    Coppola N; Rosa Z; Cirillo G; Stanzione M; Macera M; Boemio A; Grandone A; Pisaturo M; Marrone A; Adinolfi LE; Sagnelli E; Miraglia del Giudice E
    Liver Int; 2015 Aug; 35(8):1959-63. PubMed ID: 25581573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of gene-chronic hepatitis C virus infection on hepatic fibrosis and steatosis.
    Magri MC; Manchiero C; Prata TVG; Nunes AKDS; Oliveira Junior JS; Dantas BP; Tengan FM
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115025. PubMed ID: 32147132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort.
    Chen VL; Du X; Oliveri A; Chen Y; Kuppa A; Halligan BD; Province MA; Speliotes EK
    J Hepatol; 2024 Sep; 81(3):379-388. PubMed ID: 38582304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History.
    Mischitelli M; Spagnoli A; Abbatecola A; Codazzo C; Giacomelli M; Parisse S; Mancina RM; Rotondo C; Attilia F; Ginanni Corradini S; Ferri F
    Biomedicines; 2023 Jul; 11(8):. PubMed ID: 37626629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.